M.I. Garvey

1.6k total citations
36 papers, 843 citations indexed

About

M.I. Garvey is a scholar working on Epidemiology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, M.I. Garvey has authored 36 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 16 papers in Infectious Diseases and 11 papers in Molecular Medicine. Recurrent topics in M.I. Garvey's work include Antibiotic Resistance in Bacteria (11 papers), Nosocomial Infections in ICU (8 papers) and Mycobacterium research and diagnosis (7 papers). M.I. Garvey is often cited by papers focused on Antibiotic Resistance in Bacteria (11 papers), Nosocomial Infections in ICU (8 papers) and Mycobacterium research and diagnosis (7 papers). M.I. Garvey collaborates with scholars based in United Kingdom and Belgium. M.I. Garvey's co-authors include Laura J. V. Piddock, Simon Gibbons, M. Mukhlesur Rahman, C.W. Bradley, M. Wilkinson, Ryan L. Wong, Alison J. Baylay, P. Jumaa, Tracey A. Martin and Jimmy Walker and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Phytotherapy Research.

In The Last Decade

M.I. Garvey

36 papers receiving 797 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.I. Garvey United Kingdom 14 286 239 232 206 157 36 843
Laura Koeth United States 12 336 1.2× 250 1.0× 254 1.1× 380 1.8× 237 1.5× 35 1.1k
Hatim Sati United States 14 274 1.0× 175 0.7× 281 1.2× 305 1.5× 104 0.7× 31 1.1k
Binod Lekhak Nepal 17 289 1.0× 241 1.0× 252 1.1× 262 1.3× 90 0.6× 58 1.1k
Indu Shukla India 18 247 0.9× 196 0.8× 294 1.3× 205 1.0× 72 0.5× 83 1.0k
David C. Bean Australia 13 394 1.4× 176 0.7× 232 1.0× 96 0.5× 130 0.8× 34 824
Rehab Mahmoud Abd El-Baky Egypt 21 391 1.4× 465 1.9× 110 0.5× 224 1.1× 106 0.7× 60 1.2k
Deborah Ashcraft United States 16 364 1.3× 149 0.6× 223 1.0× 379 1.8× 257 1.6× 30 915
Tsu-Lan Wu Taiwan 18 406 1.4× 244 1.0× 278 1.2× 281 1.4× 133 0.8× 24 1.2k
Ahmad Farajzadeh Sheikh Iran 18 327 1.1× 313 1.3× 199 0.9× 212 1.0× 45 0.3× 58 916
James A. Ayukekbong Cameroon 10 346 1.2× 127 0.5× 163 0.7× 350 1.7× 78 0.5× 18 1.2k

Countries citing papers authored by M.I. Garvey

Since Specialization
Citations

This map shows the geographic impact of M.I. Garvey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.I. Garvey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.I. Garvey more than expected).

Fields of papers citing papers by M.I. Garvey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.I. Garvey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.I. Garvey. The network helps show where M.I. Garvey may publish in the future.

Co-authorship network of co-authors of M.I. Garvey

This figure shows the co-authorship network connecting the top 25 collaborators of M.I. Garvey. A scholar is included among the top collaborators of M.I. Garvey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.I. Garvey. M.I. Garvey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moran, Robert A., et al.. (2024). pQEB1: a hospital outbreak plasmid lineage carrying bla KPC-2. Microbial Genomics. 10(9). 3 indexed citations
2.
Garvey, M.I., et al.. (2023). The sink splash zone. Journal of Hospital Infection. 135. 154–156. 8 indexed citations
3.
Fry, Carole, C.R. Bradley, Thomas Pottage, et al.. (2022). Automated room decontamination: report of a Healthcare Infection Society Working Party. Journal of Hospital Infection. 124. 97–120. 10 indexed citations
4.
Biggs, Melanie M., et al.. (2019). Effect of using fidaxomicin on recurrent Clostridium difficile infection. Journal of Hospital Infection. 102(2). 165–167. 4 indexed citations
5.
Garvey, M.I., et al.. (2019). Impact of a PCR point of care test for influenza A/B on an acute medical unit in a large UK teaching hospital: results of an observational, pre and post intervention study. Antimicrobial Resistance and Infection Control. 8(1). 120–120. 7 indexed citations
6.
Garvey, M.I., et al.. (2018). Tap out: reducing waterborne Pseudomonas aeruginosa transmission in an intensive care unit. Journal of Hospital Infection. 102(1). 75–81. 18 indexed citations
7.
Garvey, M.I., et al.. (2018). Wiping out MRSA: effect of introducing a universal disinfection wipe in a large UK teaching hospital. Antimicrobial Resistance and Infection Control. 7(1). 155–155. 10 indexed citations
8.
Garvey, M.I., et al.. (2017). A Year in the Life of a Contaminated Heater-Cooler Unit With Mycobacterium chimaera?. Infection Control and Hospital Epidemiology. 38(6). 705–711. 9 indexed citations
9.
Wilkinson, M., et al.. (2017). The Effect of Universal Decolonization With Screening in Critical Care to Reduce MRSA Across an Entire Hospital. Infection Control and Hospital Epidemiology. 38(4). 430–435. 7 indexed citations
10.
Garvey, M.I., et al.. (2017). Decontamination of an Extracorporeal Membrane Oxygenator Contaminated With Mycobacterium chimaera. Infection Control and Hospital Epidemiology. 38(10). 1244–1246. 9 indexed citations
11.
Garvey, M.I., et al.. (2017). Waterborne Pseudomonas aeruginosa transmission in a hematology unit?. American Journal of Infection Control. 46(4). 383–386. 9 indexed citations
12.
Walker, Jimmy, Ginny Moore, Samuel Collins, et al.. (2017). Microbiological problems and biofilms associated with Mycobacterium chimaera in heater–cooler units used for cardiopulmonary bypass. Journal of Hospital Infection. 96(3). 209–220. 50 indexed citations
13.
Garvey, M.I., et al.. (2017). Can a toxin gene NAAT be used to predict toxin EIA and the severity of Clostridium difficile infection?. Antimicrobial Resistance and Infection Control. 6(1). 127–127. 23 indexed citations
14.
Garvey, M.I., et al.. (2017). Where to do water testing for Pseudomonas aeruginosa in a healthcare setting. Journal of Hospital Infection. 97(2). 192–195. 8 indexed citations
15.
Garvey, M.I., R. W. Ashford, C.W. Bradley, et al.. (2016). Decontamination of heater–cooler units associated with contamination by atypical mycobacteria. Journal of Hospital Infection. 93(3). 229–234. 46 indexed citations
16.
Garvey, M.I., C.W. Bradley, & P. Jumaa. (2016). Environmental decontamination following occupancy of a burns patient with multiple carbapenemase-producing organisms. Journal of Hospital Infection. 93(2). 136–140. 13 indexed citations
17.
Piddock, Laura J. V., M.I. Garvey, M. Mukhlesur Rahman, & Simon Gibbons. (2010). Natural and synthetic compounds such as trimethoprim behave as inhibitors of efflux in Gram-negative bacteria. Journal of Antimicrobial Chemotherapy. 65(6). 1215–1223. 91 indexed citations
18.
Garvey, M.I., M. Mukhlesur Rahman, Simon Gibbons, & Laura J. V. Piddock. (2010). Medicinal plant extracts with efflux inhibitory activity against Gram-negative bacteria. International Journal of Antimicrobial Agents. 37(2). 145–151. 103 indexed citations
19.
Garvey, M.I. & Laura J. V. Piddock. (2008). The Efflux Pump Inhibitor Reserpine Selects Multidrug-Resistant Streptococcus pneumoniae Strains That Overexpress the ABC Transporters PatA and PatB. Antimicrobial Agents and Chemotherapy. 52(5). 1677–1685. 84 indexed citations
20.
Avrain, Laëtitia, M.I. Garvey, Narcisa Mesaros, et al.. (2007). Selection of quinolone resistance in Streptococcus pneumoniae exposed in vitro to subinhibitory drug concentrations. Journal of Antimicrobial Chemotherapy. 60(5). 965–972. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026